BeiGene, Ltd. Quarterly Income Tax Expense (Benefit) in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
BeiGene, Ltd. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q3 2024.
  • BeiGene, Ltd. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $23M, a 65.5% increase year-over-year.
  • BeiGene, Ltd. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $62M, a 16% increase year-over-year.
  • BeiGene, Ltd. annual Income Tax Expense (Benefit) for 2023 was $55.9M, a 30.6% increase from 2022.
  • BeiGene, Ltd. annual Income Tax Expense (Benefit) for 2022 was $42.8M, a 122% increase from 2021.
  • BeiGene, Ltd. annual Income Tax Expense (Benefit) for 2021 was $19.2M, a 84.9% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $62M $23M +$9.12M +65.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $52.9M $14.5M +$811K +5.93% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $52.1M $7.72M -$3.77M -32.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $55.9M $16.8M +$2.41M +16.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $53.5M $13.9M +$7.61M +120% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $45.9M $13.7M +$5.53M +68% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $40.3M $11.5M -$2.46M -17.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $42.8M $14.4M -$4.68M -24.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $47.5M $6.32M +$1.28M +25.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $46.2M $8.14M +$8.37M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $37.8M $13.9M +$18.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $19.2M $19.1M +$311K +1.66% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $18.9M $5.04M +$13.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.46M -$230K +$1.25M +84.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $4.21M -$4.63M -$6.18M -398% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $10.4M $18.7M +$11.2M +148% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$783K -$8.42M -$5.21M -162% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $4.42M -$1.48M -$3.6M -169% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $8.03M $1.55M +$1.04M +199% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $6.99M $7.56M +$16.1M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$9.11M -$3.22M -$2.75M -582% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$6.37M $2.13M +$5.5M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$11.9M $519K +$3.93M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$15.8M -$8.54M -$13.5M -274% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$2.34M -$472K +$2.59M +84.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$4.93M -$3.37M -$3.57M -1776% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$1.36M -$3.41M -$3.59M -1996% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $2.24M $4.92M +$5.17M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$2.93M -$3.06M -$3.19M -2510% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $256K $201K +$66K +48.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $190K $180K +$136K +309% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $54K -$252K -$252K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $306K $127K +$127K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $179K $135K +$135K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $44K $44K +$44K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $0 $0 Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.